​

Rapport Therapeutics Ownership | Who Owns Rapport Therapeutics?

OverviewFinancialsChart

Rapport Therapeutics Ownership Summary

Rapport Therapeutics is owned by 10.80% institutional investors, 6.40% insiders, and 82.80% retail investors. Sandia investment management lp is the largest institutional shareholder, holding 0% of RAPP shares.

RAPP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRapport Therapeutics10.80%6.40%82.80%
SectorHealthcare Stocks 79.90%9.78%10.32%
IndustryBiotech Stocks 63.56%9.80%26.65%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sandia investment management lp---
Lmr partners llp---
Jennison associates---
Perceptive advisors---
Nisa investment advisors---
Crestline management, lp---
Virtus etf advisers---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sandia investment management lp---
Lmr partners llp---
Jennison associates---
Perceptive advisors---
Nisa investment advisors---
Crestline management, lp---
Virtus etf advisers---

Top Buyers

HolderShares% AssetsChange
Nisa investment advisors---18.00
Virtus etf advisers---3.74K
Sandia investment management lp---5.00K
Lmr partners llp---20.00K
Crestline management, lp---27.50K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---311.55K
Jennison associates---62.29K
Crestline management, lp---27.50K
Lmr partners llp---20.00K
Sandia investment management lp---5.00K

Sold Out

HolderChange
Nisa investment advisors-18.00
Virtus etf advisers-3.74K
Sandia investment management lp-5.00K
Lmr partners llp-20.00K
Crestline management, lp-27.50K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20257816.42%38,100,8884.65%100.10%5236.84%9-30.77%
Dec 31, 20246825.93%36,575,83928.91%1041.57%39-4.88%1385.71%
Sep 30, 20245454.29%28,374,04211.02%811.67%4117.14%7-
Jun 30, 202435-25,558,517-69-35---

Recent Insider Transactions

DateNameRoleActivityValue
May 15, 2025Bredt David Chief Scientific OfficerSell$81.26K
Apr 15, 2025Bredt David Chief Scientific OfficerSell$81.31K
Mar 14, 2025Bredt David Chief Scientific OfficerSell$92.21K
Mar 13, 2025Ignelzi Troy A. Chief Financial OfficerBuy$998.00
Mar 12, 2025Ignelzi Troy A. Chief Financial OfficerBuy$99.99K

Insider Transactions Trends

DateBuySell
2025 Q2-1
2025 Q131
2024 Q4--

RAPP Ownership FAQ

Who Owns Rapport Therapeutics?

Rapport Therapeutics shareholders are primarily institutional investors at 10.80%, followed by 6.40% insiders and 82.80% retail investors. The average institutional ownership in Rapport Therapeutics's industry, Biotech Stocks , is 63.56%, which Rapport Therapeutics falls below.

Who owns the most shares of Rapport Therapeutics?

Rapport Therapeutics’s largest shareholders are Sandia investment management lp (0 shares, 0%), Lmr partners llp (0 shares, 0%), and Jennison associates (0 shares, 0%). Together, they hold 0% of Rapport Therapeutics’s total shares outstanding.

Does Blackrock own Rapport Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rapport Therapeutics.

Who is Rapport Therapeutics’s biggest shareholder by percentage of total assets invested?

Sandia investment management lp is Rapport Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Rapport Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools